Allergy Therapeutics PLC
LSE:AGY

Watchlist Manager
Allergy Therapeutics PLC Logo
Allergy Therapeutics PLC
LSE:AGY
Watchlist
Price: 5.42 GBX -3.21% Market Closed
Market Cap: 258.3m GBX
Have any thoughts about
Allergy Therapeutics PLC?
Write Note

Wall Street
Price Targets

AGY Price Targets Summary
Allergy Therapeutics PLC

Wall Street analysts forecast AGY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AGY is 13.26 GBX with a low forecast of 13.13 GBX and a high forecast of 13.65 GBX.

Lowest
Price Target
13.13 GBX
142% Upside
Average
Price Target
13.26 GBX
145% Upside
Highest
Price Target
13.65 GBX
152% Upside
Allergy Therapeutics PLC Competitors:
Price Targets
214370
Caregen Co Ltd
23% Downside
MEGA
Mega Lifesciences PCL
20% Upside
002399
Shenzhen Hepalink Pharmaceutical Group Co Ltd
43% Downside
CPH
Cipher Pharmaceuticals Inc
41% Upside
PAHC
Phibro Animal Health Corp
32% Downside
DHG
Dhg Pharmaceutical Joint-Stock Co
6% Upside
ETON
Eton Pharmaceuticals Inc
1% Upside

Revenue
Forecast

Revenue Estimate
Allergy Therapeutics PLC

For the last 8 years the compound annual growth rate for Allergy Therapeutics PLC's revenue is 4%. The projected CAGR for the next 3 years is 12%.

4%
Past Growth
12%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Allergy Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Allergy Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AGY's stock price target?
Price Target
13.26 GBX

According to Wall Street analysts, the average 1-year price target for AGY is 13.26 GBX with a low forecast of 13.13 GBX and a high forecast of 13.65 GBX.

What is Allergy Therapeutics PLC's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Allergy Therapeutics PLC's revenue is 4%. The projected CAGR for the next 3 years is 12%.

Back to Top